Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.9 |
mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |